カテゴリー： QYResearch, 世界

スルホンアミドの世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Sulfonamides Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X19005）・商品コード：DATA909X19005
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、スルホンアミドの世界市場について調査・分析し、スルホンアミドの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（腸管吸収、吸収しにくい腸管、外用）、用途別（全身感染、腸管感染、やけど感染、その他の感染）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界のスルホンアミド市場動向
・主要企業別マーケットシェア
・スルホンアミドの種類別市場規模2014-2019
（腸管吸収、吸収しにくい腸管、外用）
・スルホンアミドの用途別市場規模2014-2019
（全身感染、腸管感染、やけど感染、その他の感染）
・スルホンアミドの北米市場：主要企業・種類別/用途別市場規模
・スルホンアミドのヨーロッパ市場：主要企業・種類別/用途別市場規模
・スルホンアミドの中国市場：主要企業・種類別/用途別市場規模
・スルホンアミドの日本国内市場：主要企業・種類別/用途別市場規模
・スルホンアミドの東南アジア市場：主要企業・種類別/用途別市場規模
・スルホンアミドのインド市場：主要企業・種類別/用途別市場規模
・スルホンアミドの中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Pfizer、Sanofi、Roche、Mylan、Teva、Bayer、Abbott、GlaxoSmithKline、Boehringer Ingelheim）
・スルホンアミドの市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but don’t surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animal’s body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohn’s disease, etc.In 2018, the global Sulfonamides market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Sulfonamides status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sulfonamides development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Pfizer
Sanofi
Roche
Mylan
Teva
Bayer
Abbott
GlaxoSmithKline
Boehringer Ingelheim

Market segment by Type, the product can be split into
Intestinal Absorption
Intestinal Tract Difficult to Absorb
External Use

Market segment by Application, split into
Systemic Infection
Intestinal Infection
Burn Infection
Other Infections

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Sulfonamides status, future forecast, growth opportunity, key market and key players.
To present the Sulfonamides development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Sulfonamides are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sulfonamides Market Size Growth Rate by Type (2014-2025)
1.4.2 Intestinal Absorption
1.4.3 Intestinal Tract Difficult to Absorb
1.4.4 External Use
1.5 Market by Application
1.5.1 Global Sulfonamides Market Share by Application (2019-2025)
1.5.2 Systemic Infection
1.5.3 Intestinal Infection
1.5.4 Burn Infection
1.5.5 Other Infections
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Sulfonamides Market Size
2.2 Sulfonamides Growth Trends by Regions
2.2.1 Sulfonamides Market Size by Regions (2019-2025)
2.2.2 Sulfonamides Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Sulfonamides Market Size by by Players
3.1.1 Global Sulfonamides Revenue by by Players (2014-2019)
3.1.2 Global Sulfonamides Revenue Market Share by by Players (2014-2019)
3.1.3 Global Sulfonamides Market Concentration Ratio (CR5 and HHI)
3.2 Sulfonamides Key Players Head office and Area Served
3.3 Key Players Sulfonamides Product/Solution/Service
3.4 Date of Enter into Sulfonamides Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Sulfonamides Market Size by Type (2014-2019)
4.2 Global Sulfonamides Market Size by Application (2014-2019)

5 North America
5.1 North America Sulfonamides Market Size (2014-2019)
5.2 Sulfonamides Key Players in North America
5.3 North America Sulfonamides Market Size by Type
5.4 North America Sulfonamides Market Size by Application

6 Europe
6.1 Europe Sulfonamides Market Size (2014-2019)
6.2 Sulfonamides Key Players in Europe
6.3 Europe Sulfonamides Market Size by Type
6.4 Europe Sulfonamides Market Size by Application

7 China
7.1 China Sulfonamides Market Size (2014-2019)
7.2 Sulfonamides Key Players in China
7.3 China Sulfonamides Market Size by Type
7.4 China Sulfonamides Market Size by Application

8 Japan
8.1 Japan Sulfonamides Market Size (2014-2019)
8.2 Sulfonamides Key Players in Japan
8.3 Japan Sulfonamides Market Size by Type
8.4 Japan Sulfonamides Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Sulfonamides Market Size (2014-2019)
9.2 Sulfonamides Key Players in Southeast Asia
9.3 Southeast Asia Sulfonamides Market Size by Type
9.4 Southeast Asia Sulfonamides Market Size by Application

10 India
10.1 India Sulfonamides Market Size (2014-2019)
10.2 Sulfonamides Key Players in India
10.3 India Sulfonamides Market Size by Type
10.4 India Sulfonamides Market Size by Application

11 Central & South America
11.1 Central & South America Sulfonamides Market Size (2014-2019)
11.2 Sulfonamides Key Players in Central & South America
11.3 Central & South America Sulfonamides Market Size by Type
11.4 Central & South America Sulfonamides Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sulfonamides Introduction
12.1.4 Pfizer Revenue in Sulfonamides Business (2014-2019))
12.1.5 Pfizer Recent Development
12.2 Sanofi
12.2.1 Sanofi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sulfonamides Introduction
12.2.4 Sanofi Revenue in Sulfonamides Business (2014-2019)
12.2.5 Sanofi Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sulfonamides Introduction
12.3.4 Roche Revenue in Sulfonamides Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Mylan
12.4.1 Mylan Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sulfonamides Introduction
12.4.4 Mylan Revenue in Sulfonamides Business (2014-2019)
12.4.5 Mylan Recent Development
12.5 Teva
12.5.1 Teva Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sulfonamides Introduction
12.5.4 Teva Revenue in Sulfonamides Business (2014-2019)
12.5.5 Teva Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sulfonamides Introduction
12.6.4 Bayer Revenue in Sulfonamides Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Abbott
12.7.1 Abbott Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sulfonamides Introduction
12.7.4 Abbott Revenue in Sulfonamides Business (2014-2019)
12.7.5 Abbott Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sulfonamides Introduction
12.8.4 GlaxoSmithKline Revenue in Sulfonamides Business (2014-2019)
12.8.5 GlaxoSmithKline Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sulfonamides Introduction
12.9.4 Boehringer Ingelheim Revenue in Sulfonamides Business (2014-2019)
12.9.5 Boehringer Ingelheim Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Sulfonamides Key Market Segments
Table Key Players Sulfonamides Covered
Table Global Sulfonamides Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Intestinal Absorption Figures
Table Key Players of Intestinal Absorption
Figuer Intestinal Tract Difficult to Absorb Figures
Table Key Players of Intestinal Tract Difficult to Absorb
Figuer External Use Figures
Table Key Players of External Use
Table Global Sulfonamides Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Sulfonamides Market Share by Application in 2018 & 2025
Figure Systemic Infection Case Studies
Figure Intestinal Infection Case Studies
Figure Burn Infection Case Studies
Figure Other Infections Case Studies
Figure Sulfonamides Report Years Considered
Figure Global Sulfonamides Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Sulfonamides Market Size by Regions 2019-2025 (Million US$)
Table Global Sulfonamides Market Size by Regions 2019-2025 (Million US$)
Table Global Sulfonamides Market Share by Regions 2014-2019
Figure Global Sulfonamides Market Share by Regions 2014-2019
Figure Global Sulfonamides Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Sulfonamides Revenue by by Players (2014-2019) (Million US$)
Table Global Sulfonamides Market Share by by Players (2014-2019)
Figure Global Sulfonamides Market Share by by Players in 2018
Table Global Sulfonamides by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Sulfonamides Product/Solution/Service
Table Date of Enter into Sulfonamides Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Sulfonamides Market Size by Type (2014-2019) (Million US$)
Table Global Sulfonamides Market Size Share by Type (2014-2019)
Figure Global Sulfonamides Market Size Market Share by Type (2014-2019)
Table Global Sulfonamides Market Size by Application (2014-2019) (Million US$)
Table Global Sulfonamides Market Size Share by Application (2014-2019)
Figure Global Sulfonamides Market Size Market Share by Application (2014-2019)
Figure Global Sulfonamides Revenue Market Share by Application in 2018
Figure North America Sulfonamides Market Size 2014-2019 (Million US$)
Table North America Key Players Sulfonamides Revenue (2018-2019) (Million US$)
Table North America Key Players Sulfonamides Market Share (2018-2019)
Table North America Sulfonamides Market Size by Type 2014-2019 (Million US$)
Table North America Sulfonamides Market Share by Type 2014-2019
Table North America Sulfonamides Market Size by Application 2014-2019 (Million US$)
Table North America Sulfonamides Market Share by Application 2014-2019
Figure Europe Sulfonamides Market Size 2014-2019 (Million US$)
Table Europe Key Players Sulfonamides Revenue (2018-2019) (Million US$)
Table Europe Key Players Sulfonamides Market Share (2018-2019)
Table Europe Sulfonamides Market Size by Type 2014-2019 (Million US$)
Table Europe Sulfonamides Market Share by Type 2014-2019
Table Europe Sulfonamides Market Size by Application 2014-2019 (Million US$)
Table Europe Sulfonamides Market Share by Application 2014-2019
Figure China Sulfonamides Market Size 2014-2019 (Million US$)
Table China Key Players Sulfonamides Revenue (2018-2019) (Million US$)
Table China Key Players Sulfonamides Market Share (2018-2019)
Table China Sulfonamides Market Size by Type 2014-2019 (Million US$)
Table China Sulfonamides Market Share by Type 2014-2019
Table China Sulfonamides Market Size by Application 2014-2019 (Million US$)
Table China Sulfonamides Market Share by Application 2014-2019
Figure Japan Sulfonamides Market Size 2014-2019 (Million US$)
Table Japan Key Players Sulfonamides Revenue (2018-2019) (Million US$)
Table Japan Key Players Sulfonamides Market Share (2018-2019)
Table Japan Sulfonamides Market Size by Type 2014-2019 (Million US$)
Table Japan Sulfonamides Market Share by Type 2014-2019
Table Japan Sulfonamides Market Size by Application 2014-2019 (Million US$)
Table Japan Sulfonamides Market Share by Application 2014-2019
Figure Southeast Asia Sulfonamides Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Sulfonamides Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Sulfonamides Market Share (2018-2019)
Table Southeast Asia Sulfonamides Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Sulfonamides Market Share by Type 2014-2019
Table Southeast Asia Sulfonamides Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Sulfonamides Market Share by Application 2014-2019
Figure India Sulfonamides Market Size 2014-2019 (Million US$)
Table India Key Players Sulfonamides Revenue (2018-2019) (Million US$)
Table India Key Players Sulfonamides Market Share (2018-2019)
Table India Sulfonamides Market Size by Type 2014-2019 (Million US$)
Table India Sulfonamides Market Share by Type 2014-2019
Table India Sulfonamides Market Size by Application 2014-2019 (Million US$)
Table India Sulfonamides Market Share by Application 2014-2019
Figure Central & South America Sulfonamides Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Sulfonamides Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Sulfonamides Market Share (2018-2019)
Table Central & South America Sulfonamides Market Size by Type 2014-2019 (Million US$)
Table Central & South America Sulfonamides Market Share by Type 2014-2019
Table Central & South America Sulfonamides Market Size by Application 2014-2019 (Million US$)
Table Central & South America Sulfonamides Market Share by Application 2014-2019
Table Pfizer Company Details
Table Pfizer Revenue in Sulfonamides Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Sulfonamides Business (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Sulfonamides Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Sulfonamides Business (2014-2019)
Table Sanofi Recent Development
Table Roche Company Details
Table Roche Revenue in Sulfonamides Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Sulfonamides Business (2014-2019)
Table Roche Recent Development
Table Mylan Company Details
Table Mylan Revenue in Sulfonamides Business 2014-2019 (Million US$)
Figure Mylan Revenue Growth Rate in Sulfonamides Business (2014-2019)
Table Mylan Recent Development
Table Teva Company Details
Table Teva Revenue in Sulfonamides Business 2014-2019 (Million US$)
Figure Teva Revenue Growth Rate in Sulfonamides Business (2014-2019)
Table Teva Recent Development
Table Bayer Company Details
Table Bayer Revenue in Sulfonamides Business 2014-2019 (Million US$)
Figure Bayer Revenue Growth Rate in Sulfonamides Business (2014-2019)
Table Bayer Recent Development
Table Abbott Company Details
Table Abbott Revenue in Sulfonamides Business 2014-2019 (Million US$)
Figure Abbott Revenue Growth Rate in Sulfonamides Business (2014-2019)
Table Abbott Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Sulfonamides Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Sulfonamides Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Sulfonamides Business 2014-2019 (Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Sulfonamides Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Global Sulfonamides Market Size by Regions (Million US$) 2019-2025
Figure Global Sulfonamides Market Size Share by Regions (2019-2025)
Figure Global Sulfonamides Market Size Share by Regions in 2025
Figure North America Sulfonamides Market Size Forecast (2019-2025)(Million USD)
Figure Europe Sulfonamides Market Size Forecast (2019-2025)(Million USD)
Figure China Sulfonamides Market Size Forecast (2019-2025)(Million USD)
Figure Japan Sulfonamides Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Sulfonamides Market Size Forecast (2019-2025)(Million USD)
Figure India Sulfonamides Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Sulfonamides Market Size Forecast (2019-2025)(Million USD)
Table Global Sulfonamides Market Size by Product (2019-2025) (Million US$)
Figure Global Sulfonamides Market Size by Product (2019-2025)
Figure Global Sulfonamides Market Size by Product in 2025
Table Global Sulfonamides Market Size by Application (2019-2025) (Million US$)
Figure Global Sulfonamides Market Size by Application (2019-2025)
Figure Global Sulfonamides Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Pfizer、Sanofi、Roche、Mylan、Teva、Bayer、Abbott、GlaxoSmithKline、Boehringer Ingelheim

★調査レポート[スルホンアミドの世界市場：規模・現状・予測2019-2025] (コード：DATA909X19005)販売に関する免責事項を必ずご確認ください。
★調査レポート[スルホンアミドの世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 膿痂疹治療の世界市場：規模・現状・予測2019-2025
    DATA909X18560 / QYResearch / 2019年11月25日 / ※当調査レポートでは、膿痂疹治療の世界市場について調査・分析し、膿痂疹治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（セファロスポリン、フシダン、リンコサミド抗生物質、ペニシリン、ペニシリン様抗生物質、プロイロムチリン、プソドモン酸A、キノロン、スルホンアミドおよび葉酸阻害剤、テトラサイクリン）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の膿痂疹治療市場動向 ・主要企業別マーケットシェア ・膿痂疹治療の種類別市場規模2014-2019 （セファロスポリン、フシダン、リンコサミド抗生物質、ペニシリン、ペニシリン様抗生物質、プロイロムチリン、プソドモン酸A、キノロン、スルホンアミドおよび葉酸阻害剤、テトラサイクリン） ・膿痂疹治療の用途別市場規模2014-2019 （病院、診療所、その他） ・膿痂疹治療の北米市場：主要企業・種類別/用途別市場規模 ・膿痂疹治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Impetigo Treatment is typically treated with an antibiotic ointment or cream that apply directly to the sores.In 2018, the global Impetigo Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Impetigo Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Impetigo Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study GlaxoSmithKline plc...
  • LTE及び5Gブロードキャストの世界市場：規模・現状・予測2019-2025
    DATA909X18652 / QYResearch / 2019年11月25日 / ※当調査レポートでは、LTE及び5Gブロードキャストの世界市場について調査・分析し、LTE及び5Gブロードキャストの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（LTE Broadcast、5G Broadcast）、用途別（ビデオオンデマンド、モバイルTV、コネクテッドカー、緊急警報、ラジオ、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のLTE及び5Gブロードキャスト市場動向 ・主要企業別マーケットシェア ・LTE及び5Gブロードキャストの種類別市場規模2014-2019 （LTE Broadcast、5G Broadcast）...The LTE broadcast technology, also known as eMBMS and LTE Multicast, is based on 3GPP's evolved Multimedia Broadcast Multicast Service (eMBMS) standard based, the global standard for video broadcast on mobile networks. The 5G broadcast technology is enhanced via the 3GPP group with Release 14 and 15 as Further Enhanced Multimedia Broadcast Multicast Service (FeMBMS).In 2018, the global LTE and 5G Broadcast market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global LTE and 5G Broadcast status,...
  • 航空用5Gの世界市場：規模・現状・予測2019-2025
    DATA909X18115 / QYResearch / 2019年11月25日 / ※当調査レポートでは、航空用5Gの世界市場について調査・分析し、航空用5Gの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（拡張モバイルブロードバンド、固定無線アクセス、その他）、用途別（航空機、空港）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の航空用5G市場動向 ・主要企業別マーケットシェア ・航空用5Gの種類別市場規模2014-2019 （拡張モバイルブロードバンド、固定無線アクセス、その他） ・航空用5Gの用途別市場規模2014-2019 （航空機、空港） ・航空用5Gの北米市場：主要企業・種類別/用途別市場規模 ・航空用5Gのヨーロッパ市場：主要企業・種類別/用途別市場規模...The fifth generation of mobile communication technology is the latest generation of cellular mobile communication technology, is an extension of 4G system. 5G's performance goals are high data rates, reduced latency, energy savings, reduced costs, increased system capacity and large-scale device connectivity.In 2018, the global 5G in Aviation market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global 5G in Aviation status, future forecast, growth opportunity, key market and key players. The study objectives are to present...

    • ◆H&Iグローバルリサーチのお客様（例）◆